A study has found targeting a protein called endocan and its related signaling pathway could be a promising new approach for treating glioblastoma, an aggressive and lethal type of brain cancer.

In an intriguing revelation from recent research, mitochondria have been shown not only to power the cell but also to ...

During islet development, beta-cell death, rather than proliferation alone, regulates beta-cell mass and shapes the immune ...

Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Marginal Zone B-cell Lymphoma.

It is used different indications such as chronic Hepatitis B, cancer adjuvant ... thymoma, thymic carcinoma. It was also under development for the treatment of advanced stage metastatic malignant ...

Since Tregs, particularly those committed in the thymus (tTregs), play a non-redundant role in the ... CVID patients are characterized by decreased class-switched memory B cells (4) but autoimmune ...

B-cell lymphoma is a type of blood cancer that affects the B lymphocytes of the immune system. They usually arise in the lymph nodes or in other lymphoid tissue, such as the spleen, bone marrow ...

Sham thymectomy involved a complete surgical procedure without thymic lobe removal. Thymectomized mice were allowed a six-week recovery period. For single-cell suspension preparation, tumors were ...

The 3-month-old girl who lives in a bubble can’t get hugs from her grandparents. Cuddling, holding and just being in the same room are off-limits too for everyone except her mother and 6-year ...

in a Lymph Node of F.M. after Antigenic Stimulation (X90), Contrasted with the"Thymus-Dependent" Zone (B) of the Lymph-Node Subcortex of C.P. (X180) — Reticular Cells Are Prominent, and ...